Saul Hertz Award

For more than a century, Dr. Saul Hertz has been recognized as one of the founding figures of nuclear medicine and theranostics. His pioneering work laid the groundwork for the clinical application of radioactive isotopes in medicine and continues to influence generations of researchers and clinicians worldwide.

Award Details

The Saul Hertz Award – South Africa honors outstanding young and mid-career scientists and clinicians who demonstrate scientific excellence and innovation in the field of theranostics. The award reflects Dr. Hertz’s enduring legacy and highlights the importance of advancing radiomolecular precision medicine on the African continent and beyond.

Chair of Award Committee

Prof. Mike Sathekge, Pretoria

Submission deadline

January 9, 2026 (23:59 CET)

Number of Awards

one

Award Period

during the TWC

Career Stage
Young or mid-career researchers or clinicians.
Ideally under 45 years of age or within 10 years of completing their doctoral degree.
Scientific Excellence
Demonstrated outstanding achievements in preclinical or clinical theranostics research.
Research Scope
Eligible work may include contributions in:
- Radiochemistry
- Radiopharmacy
- Medical physics
- Internal or external dosimetry
- Novel radioisotope development
- Radiobiology
- Clinical translation and clinical studies
- Related disciplines within theranostics

Applicants are requested to submit:

Cover Letter
Briefly outlining personal contributions and impact in the field of theranostics
Curriculum Vitae
Including a complete list of publications
Letter of Recommendation
At least one letter supporting the nomination and highlighting scientific achievements and future potential

👉 Applications must be sent no later than January 9, 2026 to: info@sasnm.com

Award Presentation

The award will be presented by Barbara Hertz, daughter of Dr. Saul Hertz, on February 1, 2026 during the 8th Theranostics World Congress, Cape Town, South Africa.

Send application